26 research outputs found
Lutembacher's syndrome: A rare combination of congenital and acquired heart disease – A case report and review of literature
Lutembacher's syndrome is defined as the rare combination of congenital atrial septal defect and acquired mitral stenosis. The haemodynamic effects of this syndrome are a result of the interplay between the relative effects of the atrial septal defect and mitral stenosis. Mitral stenosis augments the left to right shunt through the atrial septal defect. The definition of Lutembacher's syndrome has undergone many changes. The earliest description in medical literature was found in a letter written by anatomist Johann Friedrich Meckel to Albrecht von Haller in 1750.In 1916, Lutembacher described his first case of this syndrome, involving a 61-year-old woman, and he attributed the mitral valvular lesion to congenital mitral stenosis. Because the mitral stenosis was, in fact, rheumatic in aetiology, the syndrome was defined eventually as a combination of congenital atrial septal defect and acquired, almost always rheumatic, mitral stenosis.Keywords:Lutembacher's syndrome, congenital heart disease, valvular heart disease, atrial septal defect, mitral stenosi
Association of HIV-Induced Immunosuppression and Clinical Malaria in Nigerian Adults
Despite the growing body of evidence on the interaction between HIV and malaria in sub-Saharan Africa, there is a dearth of data on clinical malaria in HIV-infected patients in Nigeria. We determined the burden of clinical malaria in HIVinfected adult Nigerians and further investigated the association between their immunological status and the rates of clinical malaria. Ninety seven antiretroviral treatment-naïve HIV-infected adults were enrolled in a cross-sectional study from August to December, 2009. The participants had a complete clinical evaluation, thick and thin blood films for malaria parasites and CD4 cell count quantification. Clinical malaria was defined as having fever (temperature ≥ 37.5oC or history of fever within 48 hours) and a malaria parasite density above the median value obtained for subjects with co-existing fever and parasitaemia. Clinical malaria was diagnosed in 10 out of 97 patients (10.3%). Lower CD4 cell counts were associated with increasing rates of clinical malaria which was 0% at CD4 cell count of ≥ 500, 2.6% at 200-499 and 30% at <200 cells/μL (χ2 = 18.3, p = 0.0001). This association remained significant after controlling for other factors in a multivariate analysis (AOR=22.98, 95% C.I: 2.62-20.14, p = 0.005). An inverse relationship between CD4 cell count and parasite density was demonstrated (regression co-efficient = -0.001, p = 0.0002). More aggressive malaria control measures are highly needed in severely immunosuppressed HIV-infected patients.Keywords: HIV, Immunosuppression, Clinical malaria, Adult
Human immunodeficiency virus type-1 (HIV-1) genetic diversity and prevalence of antiretroviral drug resistance mutations in treatment-naïve adults in Jos, North Central Nigeria
The presence of human immunodeficiency virus (HIV) type-1 diversity has an impact on vaccine efficacy and drug resistance. It is important to know the circulating genetic variants and associated drug-resistance mutations in the context of scale up of antiretroviral therapy (ART) in Nigeria. The objective of this study was to determine the genetic diversity of HIV-1 and the prevalence of antiretroviral (ARV) drug resistance mutations among antiretroviral treatment-naïve HIV-1 infected patients in Jos, North Central Nigeria. Plasma samples were collected from 105 ARV drug-naïve patients enrolled for HIV care at the Jos University Teaching Hospital (JUTH) HIV Treatment Center between October 2010 and April 2011. One hundred (100) samples were successfully amplified. Viral subtyping was done using REGA subtyping tool and by phylogenetic analysis using PAUP software. The drug resistance mutations were determined using the Stanford University HIVdb sequence interpretation algorithm. HIV-1 subtypes identified were; CRF02_AG (48.0%), G (41.0%), CRF06_cpx (6.0%) and A1 (5.0%). 8% of the patients’ isolates had at least one major resistance mutation in the RT gene: Nucleoside reverse transcriptase inhibitors: M41L (1%), K65KR (1%), M184IM (1%), M184V (2%) and T215ADNT (1%), non-nucleoside reverse transcriptase inhibitors: K103N (2%), K101E (1%), G190A (1%), P225HP (1%), Y181I (1%), Y188L (1%), and Y181C (1%). Among antiretroviral (ARV) naïve patients in Jos, North Central Nigeria, the common HIV-1 subtypes was CRF_02 and G. And the prevalence of drug resistance mutations was found to be high (8%). Further study and national surveillance will be critically important to understand the clinical impact of transmitted resistance mutations on ART naïve individuals in resource limited settings.Keywords: HIV-1 subtypes, antiretroviral (ARV), treatment-naïve, drug-resistance, mutation, accessory and polymorphisms, NigeriaAfrican Journal of Biotechnology Vol. 12(17), pp. 2279-228
Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria
Patient Retention and Adherence to Antiretrovirals in a Large Antiretroviral Therapy Program in Nigeria: A Longitudinal Analysis for Risk Factors
Substantial resources and patient commitment are required to successfully scale-up antiretroviral therapy (ART) and provide appropriate HIV management in resource-limited settings. We used pharmacy refill records to evaluate risk factors for loss to follow-up (LTFU) and non-adherence to ART in a large treatment cohort in Nigeria.We reviewed clinic records of adult patients initiating ART between March 2005 and July 2006 at five health facilities. Patients were classified as LTFU if they did not return >60 days from their expected visit. Pharmacy refill rates were calculated and used to assess non-adherence. We identified risk factors associated with LTFU and non-adherence using Cox and Generalized Estimating Equation (GEE) regressions, respectively. Of 5,760 patients initiating ART, 26% were LTFU. Female gender (p < 0.001), post-secondary education (p = 0.03), and initiating treatment with zidovudine-containing (p = 0.004) or tenofovir-containing (p = 0.05) regimens were associated with decreased risk of LTFU, while patients with only primary education (p = 0.02) and those with baseline CD4 counts (cell/ml(3)) >350 and <100 were at a higher risk of LTFU compared to patients with baseline CD4 counts of 100-200. The adjusted GEE analysis showed that patients aged <35 years (p = 0.005), who traveled for >2 hours to the clinic (p = 0.03), had total ART duration of >6 months (p<0.001), and CD4 counts >200 at ART initiation were at a higher risk of non-adherence. Patients who disclosed their HIV status to spouse/family (p = 0.01) and were treated with tenofovir-containing regimens (p < or = 0.001) were more likely to be adherent.These findings formed the basis for implementing multiple pre-treatment visit preparation that promote disclosure and active community outreaching to support retention and adherence. Expansion of treatment access points of care to communities to diminish travel time may have a positive impact on adherence
Prevalence and Predictors of Tuberculosis Coinfection among HIV-Seropositive Patients Attending the Aminu Kano Teaching Hospital, Northern Nigeria
Background: The HIV/AIDS epidemic has been accompanied by a severe epidemic of tuberculosis (TB), although
the prevalence of coinfection is largely unknown, especially in developing countries, including Nigeria. The aim of this study was to determine the prevalence and predictors of TB coinfection among HIV-seropositive Nigerians.
Methods: The case files of HIV/AIDS patients attending Aminu Kano Teaching Hospital, Nigeria from January to
December 2006 were reviewed.
Results: A total of 1320 HIV/AIDS patients had complete records and were reviewed, among which 138 (10.5%)
were coinfected with TB (95% CI, 8.9% to 12.2%). Pulmonary TB was diagnosed in 103 (74.6%) patients, among
whom only 18 (17.5%) were sputum-positive. Fifty (36.2%) coinfected patients had some type of extrapulmonary TB
(EPTB); 15 had both pulmonary TB and EPTB. Among the 35 patients with EPTB only, 20 (57.1%) had abdominal
TB, 5 (14.3%) had TB adenitis, 5 (14.3%) had spinal TB, 3 (8.6%) were being monitored for tuberculous meningitis,
and 1 (2.9%) each had renal TB and tuberculous adrenalitis. The highest prevalence of TB, 13.7% (n = 28), was seen
among patients aged 41–50 years. TB coinfection was significantly associated with marital status, WHO clinical
stage, and CD4 count. Marital status (OR, 2.1; 95% CI, 1.28–3.59; P = 0.04), WHO clinical stage at presentation
(4.81; 1.42–8.34; P = 0.001), and baseline CD4 count (2.71; 1.51–6.21; P = 0.02) remained significant predictors
after adjustment for confounding.
Conclusions: The moderately high prevalence of TB among HIV-seropositive patients underscores the urgent need
for strategies that lead to rapid identification and treatment of coinfection with active or latent TB
HIV vaccine development
No Abstract.Annals of Ibadan Postgraduate Medicine Vol. 3 (2) 2005: pp. 19-2
Prevalence and Risk Factors for HIV/AIDS among Male Inmates in Jos Prison, Plateau State, Nigeria
A total of 234 male prisoners from Jos Prison had their blood samples collected and screened for antibodies against Human Immunodeficiency Virus (HIV) types I and II using Determine and Stat-pak. The objective of this study was to determine the prevalence and risk factors for HIV/AIDS among male inmates in Jos Prison, Plateau State. Percentage response to questionnaire and blood collection was 83.3%. The Seroprevalence of HIV antibodies was 17/234 (7%) of the 234 male prisoners screened. It was only one (0.4%) of the prisoners that practiced homosexuality in prison. The age 26-45 years were mostly affected constituting 56%. Seroprevalence among the prisoners (7%) was higher than the National median prevalence of HIV infection among pregnant women in year 2006 survey. This suggests the possibility of the following risk factors. Sharing of sharp objects, homosexuality and multiple sex partners during confinement.Keywords: Seroprevalence, prisoners, antibodies, homosexuality and confinementNigerian Journal of Parasitology, Vol. 32 [2] September 2011, pp.181-18
Hypertension In Type II Diabetes Mellitus In Jos University Teaching Hospital, Jos, Nigeria
Objectives: We assessed 85 patients with type II diabetes mellitus to determine the proportion of hypertension in accordance with WHO criteria. Other clinical parameters such as fundoscopic examination and urinalysis were carried out.
Methods: A cross-sectional study of hypertension in type II diabetic patients in Jos University Teaching Hospital, Jos, Nigeria
Results: Forty-two of the patients were hypertensive with only 28 (32.9%) previously diagnosed and were on treatment. Age of patient, duration of diabetes and diabetic retinopathy were significantly associated with hypertension in diabetes.
Conclusion: Hypertension is commoner in diabetes in sub-saharan Africa that it was previously believed. The finding of hypertension should arouse the possibility of the presence of microangiopathic complications in type II diabetes.
Highland Medical Research Journal Vol.1(2) 2002: 22-2